SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending due to an escalating acquisition saga, with its board rejecting a management-led buyout offer as too low and multiple strategic bidders reportedly in contention. Shareholders are actively discussing the company's significant cash reserves and book value, anticipating a much higher acquisition price while also monitoring potential Israeli government intervention regarding national security concerns over foreign ownership.

Moo Deng

MOODENG CRYPTO is seeing intense discussion and speculative interest following recent explosive price movements and high trading volume, with many in the community anticipating further significant gains due to its low market cap. However, others remain cautious, labeling it a volatile "pump and dump" given its rapid fluctuations.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow With Knife ($CAW) is trending as its community champions an organic, transparent, multi-chain project leveraging LayerZero tech across Solana, Cronos, BSC, and ETH, touting a deflationary burn mechanism and perceived utility. Enthusiasts are actively discussing its potential to lead the crypto market, contrasting with some voices calling it a pump and dump.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is trending as its community, fueled by expectations of a significant price surge reminiscent of past notable runs, actively highlights its undervalued status, AI-integrated cross-chain exchange utility, and fully diluted token supply.

Dogelon Mars

Dogelon Mars is trending amid widespread community frustration and allegations of it being a "pump and dump" scam, largely due to its severe underperformance compared to other meme coins. Despite unfulfilled promises of a "Great Burn" and metaverse developments, investors are expressing deep skepticism and disappointment over its continuous price depreciation.

TE Connectivity Plc is a company that engages in the provision of connectivity and sensor solutions for the purpose of distribution of power, signal, and data. It operates under the following segments: Transportation Solutions, Industrial Solutions, and Communications Solutions. The Transportation Solutions segment include terminals and connector systems and components, sensors, relays, antennas, and application tooling. The Industrial Solutions segment include terminals and connector systems and components, interventional medical components, relays, heat shrink tubing, and wire and cable. The Communications Solutions segment include terminals and connector systems and components, antennas, and heat shrink tubing. The company was founded in 2007 and is headquartered in Galway, Ireland.

TE Connectivity plc - Registered Shares

TE Connectivity Ltd - Registered Shares

TE Connectivity is trending after reporting strong fiscal Q1 earnings and record orders, exceeding expectations across sales and EPS, fueled by robust demand in AI, EV, and grid modernization. Community discussions underscore the company's solid fundamentals and strategic positioning for continued growth in these critical technology sectors, despite some mixed immediate market reactions.

Ralph Lauren Corp. engages in the design, marketing, and distribution of luxury lifestyle products, including apparel, footwear and accessories, home, fragrances, and hospitality categories. The firm offers products under the brands of Ralph Lauren, Ralph Lauren Luxury, Lauren Ralph Lauren, Polo Ralph Lauren, Lauren Ralph Lauren, Chaps and Hospitality. It operates through the following segments: North America, Europe, and Asia. The North America segment offers Ralph Lauren branded apparel, accessories, home furnishings, and related products made through the retail and wholesale businesses in the U.S. and Canada. The Europe segment includes Ralph Lauren branded products made through the retail and wholesale businesses in Europe and emerging markets. The Asia segment consists of Ralph Lauren branded products made through the retail and wholesale businesses in Asia, Australia, and New Zealand. The company was founded by Ralph Lauren in 1967 and is headquartered in New York, NY.

Ralph Lauren Corp - Ordinary Shares - Class A

Ralph Lauren is trending on strong earnings that consistently surpass expectations, fueled by brand elevation, full-price demand, and robust margin expansion across global markets, notably Asia. Community conversation highlights favorable consumer discretionary trends and widespread analyst upgrades, reinforcing confidence in the brand's strategic growth initiatives.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is drawing attention with strong rumors of its high-density AI-1 battery powering Honor's new smart devices and significant institutional accumulation, though investors eagerly await a concrete purchase order amidst mixed sentiment regarding manufacturing execution and a recent executive transition.

Bridgford Foods Corp. engages in the manufacture, market, and distribution of frozen and snack food products. It operates through the Frozen Food Products and Snack Food Products segments. The Frozen Food Products segment manufactures and distributes food products, including biscuits, bread dough items, roll dough items, and sandwiches. The Snack Food Products segment distributes both products manufactured by the company and third parties. The company was founded by Hugh H. Bridgford in February 1932 and is headquartered in Dallas, TX.

Bridgford Foods Corp.

Bridgford Foods Corporation

Bridgford Foods is trending as the community speculates on boosted gross margins from recent initiatives to lower beef prices and discusses the company's expanding private-label partnerships with major retailers. Investors are also viewing it as an undervalued defensive play in a strengthening food sector, despite ongoing concerns about historical shareholder value and market liquidity.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is gaining traction as a resilient community-owned memecoin, widely discussed as the "third frog" and official representation of Pepe by its creator Matt Furie, with strong accumulation noted despite broader market weakness. The community actively rallies around its long-term building efforts, believing its unique narrative and tight correlation to $PEPE and $ETH position it for significant future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Incannex Healthcare (NASDAQ:IXHL) Announces Quarterly Earnings Results

Incannex Healthcare (NASDAQ:IXHL - Get Free Report) issued its earnings results on Friday. The company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02...

Incannex Healthcare (IXHL) Expected to Announce Quarterly Earnings on Friday

Incannex Healthcare (NASDAQ:IXHL) will be releasing its Q2 2026 earnings before the market opens on Friday, February 13. (View Earnings Report at...

Short Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Decreases By 30.9%

Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 15,236,764 shares...

Incannex Healthcare (NASDAQ:IXHL) Trading Up 2.1% - Still a Buy?

Incannex Healthcare (NASDAQ:IXHL) Stock Price Up 2.1% - Time to Buy...

Incannex Healthcare (NASDAQ:IXHL) Trading Down 8.8% - Here's What Happened

Incannex Healthcare (NASDAQ:IXHL) Trading Down 8.8% - Should You Sell...

Penny Stocks To Keep An Eye On - December 3rd

iRobot, Richtech Robotics, Bitfarms, Virax Biolabs Group, Nauticus Robotics, Incannex Healthcare, and Fusion Fuel Green are the seven Penny stocks to watch today, according to MarketBeat's stock...

<ul class="summary-bullets"><li>FDA Fast Track status followed strong Phase 2 efficacy and safety results for IHL-42X.</li><li>The designation provides benefits including a rolling review and closer FDA engagement.</li><li>Stocktwits users highlighted the scale of OSA unmet need and long-term optimism.</li></ul>Incannex Healthcare shares rose nearly 15% on Wednesday after the company said the U.S. Food and Drug Administration (FDA) granted Fast Track designation to IHL-42X, its oral fixed-dose combination candidate for obstructive sleep apnea.<h2 class="st-heading-2">FDA Fast Track Status</h2>Incannex said the designation was supported by results from three completed clinical trials, including its Phase 2 RePOSA study, which showed statistically significant reductions in Apnea-Hypopnea Index with individual reductions of up to 83%, along with favorable patient-reported outcomes and an “excellent safety profile.”The company said the Fast Track status allows more frequent interactions with the FDA, eligibility for rolling review of a future New Drug Application, and potential access to Accelerated Approval and Priority Review if criteria are met.Incannex said it expects detailed written feedback from the FDA on its Phase 2 data package and development strategy and will provide updates once it has reviewed the agency’s guidance.<h2 class="st-heading-2">Generalized Anxiety Disorder Data Adds Momentum</h2>In August, the company reported&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-incannex-healthcare-surging-today/chsHHZBRdjh">positive mid-stage trial results</a> for PSX-001 in generalized anxiety disorder. The study showed statistically significant improvements across all key endpoints, including a strong reduction on the Hamilton Anxiety Rating Scale among 73 participants.<h2 class="st-heading-2">Stocktwits Traders Cheer Fast Track Status</h2>On Stocktwits, retail sentiment for Incannex was ‘extremely bullish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:971/140;" src="https://news.stocktwits-cdn.com/ixhl_ss_png_fd98f44272.webp" alt="ixhl ss.png" width="971" height="140"><figcaption>IXHL sentiment and message volume as of December 3| Source: Stocktwits</figcaption></figure>One user said, “this is incredible news. Fast tracked serves unmet medical needs, meaning this is the only pill in existence for a disease that affect nearly a billion people.”<stembedurl>https://stocktwits.com/user0987134/message/638044052</stembedurl>Another bullish user called the stock a “long hold” and expects further positive developments.<stembedurl>https://stocktwits.com/Rusty26/message/638043151</stembedurl><a href="https://stocktwits.com/symbol/IXHL">Incannex Healthcare’s stock</a> has declined 79% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Incannex Healthcare Inc. logo is seen on a smartphone and in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Incannex Healthcare Stock Soars 15% After FDA Fast Tracks Obstructive Sleep Apnea Drug

Incannex’s Fast Track designation for IHL-42X follows strong Phase 2 data and grants the program expanded FDA access and review advantages.

Equity

What Makes Incannex Healthcare Inc. (IXHL) a New Buy Stock

Incannex Healthcare Inc. (IXHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Incannex Healthcare (NASDAQ:IXHL) Trading Up 1.1% - Still a Buy?

Incannex Healthcare (NASDAQ:IXHL) Shares Up 1.1% - Time to Buy...

Incannex Healthcare Inc. (IXHL) has experienced a 234% increase in retail chatter on Stocktwits over the past seven days, while message volumes have risen 193% over the past 30 days on the platform. Shares of the company drew investor attention on Wednesday morning as it declined nearly 10% at the opening bell.Incannex is developing combination medicines for several chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalised anxiety disorder. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/IXHL">IXHL stock</a> jumped from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.<figure class="image"><img style="aspect-ratio:574/66;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_24_at_9_16_43_AM_png_8958508111.webp" alt="IXHL's Sentiment Meter and Message Volume as of 9:17 a.m. ET on Sept. 24, 2025 | Source: Stocktwits" width="574" height="66"><figcaption>IXHL's Sentiment Meter and Message Volume as of 9:17 a.m. ET on Sept. 24, 2025 | Source: Stocktwits</figcaption></figure>Last month, the company <a href="https://stocktwits.com/news-articles/markets/equity/why-is-incannex-healthcare-surging-today/chsHHZBRdjh">announced </a>positive data from a mid-stage trial evaluating PSX-001 for Generalised Anxiety Disorder (GAD). The company stated that the trial results confirm statistically significant and clinically meaningful improvements across all key endpoints assessed, including the Hamilton Anxiety Rating Scale. The trial enrolled 73 adult participants diagnosed with moderate to severe Generalised Anxiety Disorder.PSX-001, also called Psi-GAD, is a psilocybin-assisted psychotherapy treatment. Patients treated with PSX-001 in the study achieved an average 12.8-point reduction in Hamilton Anxiety Rating Scale scores from baseline, compared to a 3.6-point decrease in the placebo group.Of patients receiving treatment, 27% achieved complete disease remission, which is five times higher than the placebo rate, the company said. Additionally, the firm is exploring strategic partnerships to accelerate development and broaden global access to PSX-001.The company’s other two clinical-stage product candidates, IHL-42X and IHL-675A, are in different stages of development. While IHL-42X has completed a mid-stage clinical trial in obstructive sleep apnoea, IHL-675A is currently in a mid-stage clinical development program for the treatment of inflammatory conditions such as Arthritis.Incannex also <a href="https://stocktwits.com/news-articles/markets/equity/incannex-stock-soars-after-board-authorizes-20-million-share-repurchase-program/chsZIp3RdK2">authorized</a> a $20 million share repurchase program in August. CEO Joel Latham had stated that the program reflects the company’s confidence in the strength of its pipelines and the opportunities ahead. “We believe the current market valuation does not accurately reflect the significant progress we have made across our clinical programs,” he said.A Stocktwits user, meanwhile, expressed hopes for a partnership or buyout announcement on the company’s next earnings announcement.<stembedurl>https://stocktwits.com/IKEGAI/message/629801176</stembedurl>Shares of the company slumped 71% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/acadia-health-care-stock-surges-pre-market-after-activist-hedge-fund-reportedly-seeks-board-revamp/chD1bdjR33W">Acadia Healthcare Stock Surges After Activist Hedge Fund Reportedly Seeks Board Revamp</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Incannex Healthcare Stock Sees Retail Chatter Explode 234% Over Last Week

The company is developing combination medicines for several chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalised anxiety disorder.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$0.2691
Prev Close	$0.269
Open	$0.2747
Dividend Yield	0.00%
50-Day Moving Average	$0.3667
Beta	-0.16
Avg. Volume	7.35M
PE Ratio	-0.25

52-Week High	$1.82
52-Week Low	$0.08
Market Capitalization	$93.17M
EPS (Annual)	-$1.36
Price to Book	1.22
Revenue Per Employee	$7,166.67

IXHL
Incannex Healthcare Limited - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest IXHL News

IXHLIncannex Healthcare Limited - ADR